Literature DB >> 32143930

Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis.

Sara Grineski1, Danielle X Morales2, Timothy Collins3, Jacob Wilkes4, Joshua L Bonkowsky5.   

Abstract

OBJECTIVE: To examine disparities in the diagnosis of leukodystrophies including geographic factors and access to specialty centers. STUDY
DESIGN: Retrospective cohort study of pediatric patients admitted to Pediatric Health Information System hospitals. Patients with leukodystrophy were identified with International Classification of Diseases, Tenth Revision, Clinical Modification diagnostic codes for any of 4 leukodystrophies (X-linked adrenoleukodystrophy, Hurler disease, Krabbe disease, and metachromatic leukodystrophy). We used 3-level hierarchical generalized logistic modeling to predict diagnosis of a leukodystrophy based on distance traveled for hospital, neighborhood composition, urban/rural context, and access to specialty center.
RESULTS: We identified 501 patients with leukodystrophy. Patients seen at a leukodystrophy center of excellence hospital were 1.73 times more likely to be diagnosed than patients at non-center of excellence hospitals. Patients who traveled farther were more likely to be diagnosed than those who traveled shorter. Patients living in a Health Professionals Shortage Area zip code were 0.86 times less likely to be diagnosed than those living in a non-Health Professionals Shortage Area zip code.
CONCLUSIONS: Geographic factors affect the diagnosis of leukodystrophies in pediatric patients, particularly in regard to access to a center with expertise in leukodystrophies. Our findings suggest a need for improving access to pediatric specialists and possibly deploying specialists or diagnostic testing more broadly.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diagnosis; disparities; geographic; leukodystrophy; pediatric; specialty

Mesh:

Year:  2020        PMID: 32143930      PMCID: PMC7186149          DOI: 10.1016/j.jpeds.2020.01.063

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

Review 1.  Rare diseases, orphan drugs and their regulation: questions and misconceptions.

Authors:  Erik Tambuyzer
Journal:  Nat Rev Drug Discov       Date:  2010-11-09       Impact factor: 84.694

2.  Whole exome sequencing in patients with white matter abnormalities.

Authors:  Adeline Vanderver; Cas Simons; Guy Helman; Joanna Crawford; Nicole I Wolf; Geneviève Bernard; Amy Pizzino; Johanna L Schmidt; Asako Takanohashi; David Miller; Amirah Khouzam; Vani Rajan; Erica Ramos; Shimul Chowdhury; Tina Hambuch; Kelin Ru; Gregory J Baillie; Sean M Grimmond; Ljubica Caldovic; Joseph Devaney; Miriam Bloom; Sarah H Evans; Jennifer L P Murphy; Nathan McNeill; Brent L Fogel; Raphael Schiffmann; Marjo S van der Knaap; Ryan J Taft
Journal:  Ann Neurol       Date:  2016-05-09       Impact factor: 10.422

3.  Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.

Authors:  Jerry R Mendell; Samiah Al-Zaidy; Richard Shell; W Dave Arnold; Louise R Rodino-Klapac; Thomas W Prior; Linda Lowes; Lindsay Alfano; Katherine Berry; Kathleen Church; John T Kissel; Sukumar Nagendran; James L'Italien; Douglas M Sproule; Courtney Wells; Jessica A Cardenas; Marjet D Heitzer; Allan Kaspar; Sarah Corcoran; Lyndsey Braun; Shibi Likhite; Carlos Miranda; Kathrin Meyer; K D Foust; Arthur H M Burghes; Brian K Kaspar
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

Review 4.  Emerging treatments for pediatric leukodystrophies.

Authors:  Guy Helman; Keith Van Haren; Maria L Escolar; Adeline Vanderver
Journal:  Pediatr Clin North Am       Date:  2015-04-08       Impact factor: 3.278

5.  Metachromatic leukodystrophy in the Navajo: fallout of the American-Indian wars of the nineteenth century.

Authors:  S Holve; D Hu; S E McCandless
Journal:  Am J Med Genet       Date:  2001-07-01

6.  The burden of inherited leukodystrophies in children.

Authors:  J L Bonkowsky; C Nelson; J L Kingston; F M Filloux; M B Mundorff; R Srivastava
Journal:  Neurology       Date:  2010-07-21       Impact factor: 9.910

7.  Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.

Authors:  Florian Eichler; Christine Duncan; Patricia L Musolino; Paul J Orchard; Satiro De Oliveira; Adrian J Thrasher; Myriam Armant; Colleen Dansereau; Troy C Lund; Weston P Miller; Gerald V Raymond; Raman Sankar; Ami J Shah; Caroline Sevin; H Bobby Gaspar; Paul Gissen; Hernan Amartino; Drago Bratkovic; Nicholas J C Smith; Asif M Paker; Esther Shamir; Tara O'Meara; David Davidson; Patrick Aubourg; David A Williams
Journal:  N Engl J Med       Date:  2017-10-04       Impact factor: 91.245

Review 8.  The leukodystrophies.

Authors:  Hannah B Gordon; Anthea Letsou; Joshua L Bonkowsky
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

9.  Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.

Authors:  Kimberly Splinter; David R Adams; Carlos A Bacino; Hugo J Bellen; Jonathan A Bernstein; Alys M Cheatle-Jarvela; Christine M Eng; Cecilia Esteves; William A Gahl; Rizwan Hamid; Howard J Jacob; Bijal Kikani; David M Koeller; Isaac S Kohane; Brendan H Lee; Joseph Loscalzo; Xi Luo; Alexa T McCray; Thomas O Metz; John J Mulvihill; Stanley F Nelson; Christina G S Palmer; John A Phillips; Leslie Pick; John H Postlethwait; Chloe Reuter; Vandana Shashi; David A Sweetser; Cynthia J Tifft; Nicole M Walley; Michael F Wangler; Monte Westerfield; Matthew T Wheeler; Anastasia L Wise; Elizabeth A Worthey; Shinya Yamamoto; Euan A Ashley
Journal:  N Engl J Med       Date:  2018-10-10       Impact factor: 91.245

Review 10.  Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement.

Authors:  Supriya Bavisetty; Wayne W Grody; Shahram Yazdani
Journal:  Rare Dis       Date:  2013-01-28
View more
  5 in total

1.  Time to Transplant in X-Linked Adrenoleukodystrophy.

Authors:  Joshua L Bonkowsky; Jacob Wilkes
Journal:  J Child Neurol       Date:  2022-03-03       Impact factor: 2.363

2.  Racial/Ethnic and Insurance Status Disparities in Distance Traveled to Access Children's Hospital Care for Severe Illness: the Case of Children with Leukodystrophies.

Authors:  Sara E Grineski; Danielle X Morales; Timothy Collins; Jacob Wilkes; Joshua L Bonkowsky
Journal:  J Racial Ethn Health Disparities       Date:  2020-02-24

3.  Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients.

Authors:  Shanice Beerepoot; Silvy J M van Dooren; Gajja S Salomons; Jaap Jan Boelens; Edwin H Jacobs; Marjo S van der Knaap; André B P van Kuilenburg; Nicole I Wolf
Journal:  Neurogenetics       Date:  2020-07-07       Impact factor: 2.660

4.  National U.S. Patient and Transplant Data for Krabbe Disease.

Authors:  Gabrielle Ghabash; Jacob Wilkes; Joshua L Bonkowsky
Journal:  Front Pediatr       Date:  2021-11-11       Impact factor: 3.418

5.  An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases.

Authors:  Mallory J Owen; Sebastien Lefebvre; Christian Hansen; Chris M Kunard; David P Dimmock; Laurie D Smith; Gunter Scharer; Rebecca Mardach; Mary J Willis; Annette Feigenbaum; Anna-Kaisa Niemi; Yan Ding; Luca Van Der Kraan; Katarzyna Ellsworth; Lucia Guidugli; Bryan R Lajoie; Timothy K McPhail; Shyamal S Mehtalia; Kevin K Chau; Yong H Kwon; Zhanyang Zhu; Sergey Batalov; Shimul Chowdhury; Seema Rego; James Perry; Mark Speziale; Mark Nespeca; Meredith S Wright; Martin G Reese; Francisco M De La Vega; Joe Azure; Erwin Frise; Charlene Son Rigby; Sandy White; Charlotte A Hobbs; Sheldon Gilmer; Gail Knight; Albert Oriol; Jerica Lenberg; Shareef A Nahas; Kate Perofsky; Kyu Kim; Jeanne Carroll; Nicole G Coufal; Erica Sanford; Kristen Wigby; Jacqueline Weir; Vicki S Thomson; Louise Fraser; Seka S Lazare; Yoon H Shin; Haiying Grunenwald; Richard Lee; David Jones; Duke Tran; Andrew Gross; Patrick Daigle; Anne Case; Marisa Lue; James A Richardson; John Reynders; Thomas Defay; Kevin P Hall; Narayanan Veeraraghavan; Stephen F Kingsmore
Journal:  Nat Commun       Date:  2022-07-26       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.